SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
May 07, 2024 09:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic...
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 07, 2024 08:30 ET
|
Inozyme Pharma Inc.
Inozyme reported financial results for the first quarter ended March 31, 2024 and provided business highlights.
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus
May 07, 2024 08:00 ET
|
Eterna Therapeutics
Eterna Therapeutics to present a poster at ASGCT on the Development of a mRNA-Engineered iPSC Line, via Targeted Insertion of HLA-E at the B2M Locus
Stallion Uranium Intersects Significant Conductive Structure
May 07, 2024 06:00 ET
|
Stallion Uranium Corp.
Stallion’s winter 2024 drilling program at the Coffer project has yielded remarkable results, identifying a large conductive structure and 1.4 km of anomal
Terranet AB – Interim report Q1 2024
May 07, 2024 02:00 ET
|
Terranet
Significant events during the first quarter - Successful prototype demo in lab conducted at the end of March During the first quarter of the year, product development focused...
Terranet AB – Delårsrapport Q1 2024
May 07, 2024 02:00 ET
|
Terranet
Väsentliga händelser under första kvartalet - Framgångsrik prototypdemo i labb genomförd i slutet av mars Under årets första kvartal har produktutvecklingen...
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
May 06, 2024 17:00 ET
|
EUDA Health Holdings Ltd
SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind...
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
May 06, 2024 16:30 ET
|
Day One Biopharmaceuticals, Inc.
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) First prescriptions received in the U.S. ...
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
May 06, 2024 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
May 06, 2024 16:05 ET
|
Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...